COVID-19 | Specialty

The OncLive COVID-19 condition center page is a comprehensive resource for clinical news and expert insights on how the COVID-19 pandemic has impacted multiple areas of oncology care and practice. This page features news articles, interviews in written and video format, and podcasts encompassing data of patients with COVID-19 and cancer, oncology drugs being tested against the virus, vaccine information for patients with cancer, and more.

The COVID-19 Pandemic Will Have Long-Term Impact on Oncology Practices

March 29th 2021

The COVID-19 pandemic created new patient care challenges in oncology, such as how to reduce risks of virus exposure for patients who may be immunocompromised and switching from in-person visits to telemedicine.

Dr. del Rio on the Reactogenicity of the COVID-19 Vaccines

March 24th 2021

Carlos del Rio, MD, discusses the reactogenicity of the COVID-19 vaccines.

Dr. Ip on Remaining Questions With the COVID-19 Vaccine in Oncology

March 23rd 2021

Andrew Ip, MD, MS, discusses remaining questions with the COVID-19 vaccine in patients with cancer.

Diversity Gap Persists for Racial and Ethnic Minorities in Oncology

March 23rd 2021

Despite many diversity initiative over the past 10 years, a lack of meaningful representation of certain racial and ethnic minorities continues in the oncology workforce.

COVID-19 Pandemic Causes Apprehension for Trial Enrollment Among Patients With Cancer

March 19th 2021

The majority of respondents in a survey study indicated that the COVID-19 pandemic made no difference in their decision to participate in an oncology clinical trial; however, the remaining respondents were more than 7 times more likely to indicate that the pandemic made them less likely to enroll in a clinical trial

HCC-TAG Conference to Highlight Headway Made in HCC Care Amidst COVID-19 Pandemic

March 19th 2021

Anjana Pillai, MD, discusses recent advances made in the HCC treatment paradigm, as well as what the conference will offer to healthcare providers working in the field.

Pandemic Causes Drop in New Oncology Trials, But the Tide May Be Turning

March 18th 2021

The coronavirus 2019 pandemic caused a 60% drop in the initiation of new clinical trials for anticancer therapies compared with prior years.

Cancer Screening, Diagnosis Rates Nearly Recover to Pre–COVID-19 Levels in the Northeastern United States

March 17th 2021

Although cancer screening rates and ensuing diagnoses dropped significantly during the height of the COVID-19 pandemic, testing rates from June 2020 through September 2020 have nearly returned to pre-pandemic levels.

COVID-19 Spurs New Therapy Trends

March 12th 2021

When the coronavirus disease 2019 pandemic started upending health care services throughout the United States a year ago, the oncology community moved quickly to develop guidance on selecting therapies and setting treatment schedules for many cancers to allow for less frequent in-patient visits to clinics and infusion centers.

Dr. Au on the Rationale to Evaluate Antiviral Immunity From COVID-19 in Cancer

March 11th 2021

Lewis Au, MBBS, BMedSci, FRACP, discusses the rationale to evaluate antiviral immunity from COVID-19 among patients with cancer.

COVID-19 Vaccines Put Spotlight on DNA Technologies in Cancer Research

March 10th 2021

FDA approval of vaccines to prevent coronavirus disease 2019 is giving new focus to technologies with the potential to treat patients with cancer.

An Autopsy of Breast Cancer Management Amidst the COVID-19 Pandemic

March 7th 2021

One year into the COVID-19 pandemic has allowed for some reflection on the different evolutions that the oncology community went through in response to the many challenges posed by the virus.

Maintenance Lenalidomide Safe, Should Be Continued in Patients With Myeloma Who Contract COVID-19

March 5th 2021

Maintenance treatment with lenalidomide was found to be a safe treatment for patients with multiple myeloma who are diagnosed with COVID-19, supporting use of the immunomodulatory drug in this patient population.

Oncology Sales Forces Rely on Virtual Meetings During Pandemic

March 4th 2021

The COVID-19 pandemic has affected the ability of oncology sales forces to access physicians and advanced practice providers, with fewer face-to-face meetings and fewer interactions overall.

Dr. Bociek on Outcomes of Patients With CLL and COVID-19

March 2nd 2021

R. Gregory Bociek, MD, discusses outcomes for patients with chronic lymphocytic leukemia and COVID-19.

Dr. Kulasinghe on Identifying COVID-19–Associated Gene Signatures Through Spatial Transcriptomics

February 26th 2021

Arutha Kulasinghe, PhD, discusses identifying COVID-19–associated gene signatures through spatial transcriptomics.

Dr. Lavery on Cancer Care in Ireland Amidst the COVID-19 Pandemic

February 26th 2021

Anita Lavery, MD, MRCP, discusses the current state of cancer care during the COVID-19 pandemic in Ireland.

Dr. Ip on the Challenges of Treating Patients With Hematologic Malignancies and COVID-19

February 25th 2021

Andrew Ip, MD, MS, discusses the challenges of treating patients with hematologic malignancies and COVID-19.

Dr. del Rio on Selecting Between Available Vaccines for COVID-19

February 25th 2021

Carlos del Rio, MD, discusses factors to consider when selecting between available vaccines for COVID-19.

Dr. Garassino on COVID-19 Vaccine Distribution to Patients With Cancer in Italy

February 25th 2021

Marina Garassino, MD, discusses the distribution of the coronavirus disease 2019 vaccine to patients with cancer in Italy.